IDEXX LABORATORIES INC /DE (IDXX) Stock Price, Financials & Summary

Price chart

Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20Oct 23

Key dataOct 23, 2026

Open$564.80

From 52W high−26.91%

Volume397866.00

Market cap$44.15B

P/E (TTM)39.4x

P/S (TTM)9.7x

Div yield—

Key dataOct 23, 2026

Open

$564.80

From 52W high

−26.91%

Volume

397866.00

Market cap

$44.15B

ValuationView details →

P/E (Fwd)

34.6x

EV/EBITDA

27.8x

P/E (TTM)

39.4x

RSI (14)

62.5

MomentumView details →

1D Return

−1.13%

YTD Return

−17.03%

SummaryUpdated Jun 1, 2026

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is a leading global provider of veterinary diagnostics and water quality testing solutions founded in 1983 and headquartered in Westbrook, Maine. The company went public in 1991 and has grown to become the dominant player in companion animal veterinary diagnostics, serving veterinary clinics, reference laboratories, and water testing markets worldwide. IDEXX operates through four main segments: Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy (LPD), and Other segments, with the companion animal business representing the vast majority of revenues and profits.

Ask drillr about IDEXX LABORATORIES INC /DE →

ValuationView details →

P/E (Fwd)

34.6x

P/E (TTM)

39.4x

EV/EBITDA

27.8x

EV/Sales

9.9x

P/S (TTM)

9.7x

P/B (TTM)

27.4x

ProfitabilityView details →

Gross Margin

62.45%

Net Margin

25.03%

EBITDA Margin

35.53%

ROE (TTM)

70.67%

ROA (TTM)

33.11%

Asset Turnover

1.33x

GrowthView details →

Revenue YoY

+12.77%

EPS YoY

+17.69%

FCF YoY

+61.51%

Revenue CAGR 3Y

+8.52%

EPS CAGR 3Y

+17.49%

EBITDA YoY

+15.39%

MomentumView details →

1D Return

−1.13%

YTD Return

−17.03%

1Y Return

−12.41%

RSI (14)

62.5

vs 50D SMA

+5.26%

vs 200D SMA

−2.66%

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

1.17x

Quick Ratio

0.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$4.27

EPS Surprise

8.38%

Beats (12Q)

11/12

Next Q EPS Est

$3.39

Avg Surprise (4Q)

4.78%

Rev Surprise

1.36%

Financials snapshotView financials →

Revenue (TTM)

4.55B

Net Income (TTM)

1.14B

Op. CF (TTM)

1.37B

Next earningsNov 2, 2026 →

Latest newsMore news →

IDEXX Laboratories scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before market open, with an analyst conference call at 8:30 a.m. ET that day.24d ago

IDEXX Laboratories acquired CoVetAI Inc., prompting Chicago Pacific Founders to exit its investment in the company.25d ago

Similar companies

Waters CorporationWAT IQVIA Holdings Inc.IQV Illumina, Inc.ILMN Agilent Technologies, Inc.A 昭衍新药603127.SH Natera, Inc.NTRA Find similar companies →

Latest newsMore news →

IDEXX Laboratories scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before market open, with an analyst conference call at 8:30 a.m. ET that day.24d ago IDEXX Laboratories acquired CoVetAI Inc., prompting Chicago Pacific Founders to exit its investment in the company.25d ago IDEXX Laboratories acquired CoVetAI to advance veterinary workflow intelligence.39d ago